
Eyecelerator @ AAO 2025
Register Now to Join Us on Oct. 16 | Orlando, FL
PROGRAM AGENDA
Registration + Networking Breakfast
7:00 – 8:00 a.m.
Registration and breakfast
​
Welcome Remarks
8:00 – 8:15 a.m.
Welcome and Overview of Eyecelerator @ AAO 2025​​​​
​
Speakers:
-
Stephen D. McLeod, MD, CEO, American Academy of Ophthalmology
-
Gil Kliman, MD, MBA, Program Director
-
Allen C. Ho, MD, Retina Program Director
S1: Do the Eyes Have It? Ophthalmic Commercial Dynamics and Investment Opportunities
8:15 – 9:00 a.m.
​​​Moderators:
-
Gil Kliman, MD, MBA, Program Director
-
Ramin Valian, VP, Eyecare Global Pipeline and Commercial Strategy, AbbVie
​
​Speakers:
Market Overview
-
Kristen Harmon Ingenito, MBA, CEO, Market Scope
​
Capital Market Overview
-
Neha Begwani, MBA, Managing Director, Healthcare Investment,
Morgan Stanley
​
VC Overview
-
Garrett Hamontree, MBA, Partner, Visionary Ventures
​
​Panel:
-
Neha Begwani, MBA, Managing Director, Healthcare Investment,
Morgan Stanley -
Garrett Hamontree, MBA, Partner, Visionary Ventures
-
Kristen Harmon Ingenito, MBA, CEO, Market Scope
-
James C. Murray, JD, Founder and Managing Member, ExSight Ventures, LLC
-
Roger Zhang, PhD, VP, Samsara BioCapital
S2: Robotics in Ophthalmology: From Vision to Reality
9:00 – 9:45 a.m.
​​​Moderators:
-
Reza Zadno, PhD, Former President & CEO, PROCEPT BioRobotics
-
Lejla Vajzovic, MD, Program Committee
​
Speaker:
Medical Robotics
-
Frederic Moll, MD, MS, Co-Founder, Intuitive, Co-Founder & Partner, Sonder Capital
Panel:
-
David F. Chang, MD, Chair, Clinical Advisory Board, ForSight Robotics
-
Jean-Pierre Hubschman, MD, Co-Founder and CEO, Horizon Surgical System
-
Franck Leveiller, PhD, SVP, Chief Scientific Officer and Senior Vice President, Head Global Research & Development, Alcon
-
Frederic Moll, MD, MS, Co-Founder, Intuitive, Co-Founder & Partner, Sonder Capital
-
Michelle Tarver, MD, PhD, Center Director, CDHR, FDA
Networking Break (sponsored by Ocular Therapeutix)
9:45 – 10:15 a.m.
Networking Break
S3: Oculomics: Can Ocular Diagnostics with AI Improve Systemic Disease Management?
10:15 – 11:00 a.m.
​Moderators:
-
Allen C. Ho, MD, Retina Program Director
-
Charles C. Wykoff, MD, PhD, Program Committee
​​
​Speakers:
-
Carol Y. Cheung, PhD, Professor, Department of Ophthalmology & Visual Sciences, The Chinese University of Hong Kong
-
Aaron Y. Lee, MD, Arthur W. Stickle Distinguished Professor and Chair, Hardesty Department of Ophthalmology and Visual Sciences, Washington University School of Medicine
-
Cecilia S. Lee, MD, MS, Professor of Ophthalmology, Washington University School of Medicine
-
David Rhew, MD, Global CMO and Vice President of Healthcare, Microsoft
-
Joel S. Schuman, MD, Professor and Vice Chair for Research Innovation, Wills Eye Hospital
-
Robert C. Sergott, MD, Executive Director, Jefferson EyeBrain Center
-
Ali Tafreshi, CEO and President, Topcon Healthcare, Inc., Founding Member, Alliance for Healthcare from the Eye
​​
​Panel:
-
Carol Y. Cheung, PhD, Professor, Department of Ophthalmology & Visual Sciences, The Chinese University of Hong Kong
-
Aaron Y. Lee, MD, Arthur W. Stickle Distinguished Professor and Chair, Hardesty Department of Ophthalmology and Visual Sciences, Washington University School of Medicine
-
Cecilia S. Lee, MD, MS, Professor of Ophthalmology, Washington University School of Medicine
-
David Rhew, MD, Global CMO and Vice President of Healthcare, Microsoft
-
Joel S. Schuman, MD, Professor and Vice Chair for Research Innovation, Wills Eye Hospital
-
Robert C. Sergott, MD, Executive Director, Jefferson EyeBrain Center
-
Ali Tafreshi, CEO and President, Topcon Healthcare, Inc., Founding Member, Alliance for Healthcare from the Eye
S4: Strategic Pathways: Driving Value Through Ophthalmic Innovation and Acquisition
11:00 – 11:45 a.m.
​Moderators:
-
Robert L. Avery, MD, Program Co-Chair
-
Rajesh K. Rajpal, MD, Program Committee
​​​
Panel:
-
Laurent Attias, SVP Corporate Strategy, BD&L and M&A, Alcon
-
Pravin U. Dugel, MD, President & CEO, Ocular Therapeutix
-
Andrew Gitkin, Senior Managing Director, Leerink Partners
-
David R. Guyer, MD, CEO, EyeBio, A Subsidiary of Merck & Co., Inc.
-
Esther Melo, PhD, BD&L Director, Partnering, Roche Pharma
-
Peter Sandor, MD, MBA, EVP Head of Corporate Strategy, Astellas Pharma
S5: The Winning Pitch Challenge
11:45 a.m. –
12:30 p.m.
The Shark Tank-style competition will feature pitches from these three early-stage ophthalmology innovators, with judges and the audience awarding cash prizes worth $45,000. ​
​
​Finalists:
-
Leanne Labriola, DO, MBA: InnSight Technology
-
Nikolas Pontikos, PhD: Eye2Gene Ltd
-
Joaquin Sosa-Lockward, MD: Neobuckle
​
​Moderators:
-
Vance Thompson, MD, Ophthalmologist, Vance Thompson Vision
-
Julie M. Schallhorn, MD, MS, Professor, Ophthalmology, University of California, San Francisco
​​​
Judges:
-
Erin Powers, MBA, President, North America, Johnson & Johnson Surgical Vision
-
Namrata Saroj, OD, Chief Business Officer, Ocular Therapeutix, Inc.
-
Firas M. Rahhal, MD, Partner, ExSight Ventures, LLC
Lunch and Networking Break
12:30 – 1:15 p.m.
Enjoy a bite to eat with your colleagues.​​
Presenting Company Showcases
1:15 – 2:45 p.m.
Forty-two companies present innovative new treatments, products, and services. Three breakout rooms will operate simultaneously for each segment. Links for showcase schedules will be updated below:
​
Anterior Segment - Room: W221
Moderators:
-
Julie M. Schallhorn, MD, MS, Program Committee
-
Kuldev Singh, MD, Program Committee
Delivery / Device / Surgical- Room: W222
Moderators:
-
Robert L. Avery, MD, Program Co-Chair
-
Rajesh K. Rajpal, MD, Program Committee
​
Posterior / Retina - Room: W230
Moderators:
-
Rishi P. Singh, MD, Incoming Chair, Department of Ophthalmology, Mass Eye and Ear, Mass General Brigham
-
Lejla Vajzovic, MD, Program Committee
Networking Break
2:45 – 3:10 p.m.
Networking Break ​
Innovator Award
3:10 – 3:30 p.m.
Presentation of Eyecelerator’s Innovator Award to Glaukos
​
​Moderator:
-
James V. Mazzo, Executive Chair, Neurotech Pharmaceuticals, Inc.
Panel:
​​
-
Thomas W. Burns, Chairman & CEO, Glaukos
-
Robert L. Davis, JD, SVP, General Counsel & Business Development, Glaukos
-
Joseph E. Gilliam, President & COO, Glaukos
-
Tomas Navratil, PhD, Chief Development Officer, Glaukos
-
Thomas W. Samuelson, MD, Founding Partner, Minnesota Eye Consultants
S6: Regulatory Evolution: What's New and Next at the FDA
3:30 – 4:15 p.m.
​​Moderators:
-
Kuldev Singh, MD, Program Committee
-
Julia A. Haller, MD, Ophthalmologist-in-Chief, Wills Eye Hospital
Panel:
​​
-
Michelle E. Tarver, MD, PhD, Center Director, CDRH, FDA
-
Heidi I. Becker, MD, Ophthalmology Clinical Reviewer, CBER, FDA
People’s Choice Awards & Closing Bell
4:15 – 4:30 p.m.
The program committee wraps the day with the People's Choice recognition of best presenting company by segment.
​
Reception (sponsored by EyeBio)
4:30 – 5:15 p.m.
Enjoy refreshments and connect!